Jalalon, Jonard D.
HRN: 21-73-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
MUPIROCIN 2%, 15G (TUBE)
08/09/2022
08/16/2022
TOPICAL
2%
Bid
Open Stab Wound
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes